NSG 552 EXAM 3:
PSYCHOPHARMACOLOGY REVIEW
QUESTIONS AND ANSWERS 100% PASS
2026 EDITION
Naltrexone class - ANS Opioid receptor antagonist
Naltrexone can be used for - ANS both ETOH and opioid use disorders
What does naltrexone do - ANS Reduces desire/cravings, First line treatment, Will precipitate
withdrawal in patients with physical opioid dependence
First line treatment in maintaining abstinence after detox - ANS acamprosate
acamprosate can be used - ANS in liver disease- not metabolized by the liver (not impacted
by ETOH use). Can be administered to patients with hepatitis, liver disease, and those who
continue drinking alcohol
acamprosate Contraindicated in - ANS severe renal disease
acamprosate helps with - ANS Decreasing cravings
1
@2026 EDITION ALLRIGHTS RESERVED
, ETOH 2nd line treatment - ANS disulfiram (Antabuse)
disulfiram (Antabuse) causes - ANS aversion reaction to ETOH (flushing, headaches, n/v,
palpitation, SOB, vertigo, hypotension)
disulfiram (Antabuse) Do not - ANS administer until the person has been alcohol free at least
12 hours
disulfiram (Antabuse) MOA - ANS Blocks enzyme (aldehyde dehydrogenase) in the liver
ETOH withdrawal- Benzos - ANS To keep patient calm and lightly sedated
Benzos MOA - ANS Enhance the effects of GABA
Meds used in mild alcohol withdrawal - ANS Tegretol, Valproic or Gabapentin
ETHO meds for nutritional deficiencies - ANS Thiamine, folic acid, and multivitamin - 'Banana
bag'
Wernicke's encephalopathy treatment - ANS Parenteral Thiamine and Folate
Wernicke's encephalopathy cause - ANS B1 deficiency
Cocaine mechanism - ANS reuptake of dopamine, epinephrine, and NE = Stimulant effect
Cocaine effects on the body - ANS has vasoconstrictive effects = can cause MI, stroke
Cocaine treatment options - ANS NO FDA approved med; Off-label = naltrexone, modafinil,
Topamax
2
@2026 EDITION ALLRIGHTS RESERVED
PSYCHOPHARMACOLOGY REVIEW
QUESTIONS AND ANSWERS 100% PASS
2026 EDITION
Naltrexone class - ANS Opioid receptor antagonist
Naltrexone can be used for - ANS both ETOH and opioid use disorders
What does naltrexone do - ANS Reduces desire/cravings, First line treatment, Will precipitate
withdrawal in patients with physical opioid dependence
First line treatment in maintaining abstinence after detox - ANS acamprosate
acamprosate can be used - ANS in liver disease- not metabolized by the liver (not impacted
by ETOH use). Can be administered to patients with hepatitis, liver disease, and those who
continue drinking alcohol
acamprosate Contraindicated in - ANS severe renal disease
acamprosate helps with - ANS Decreasing cravings
1
@2026 EDITION ALLRIGHTS RESERVED
, ETOH 2nd line treatment - ANS disulfiram (Antabuse)
disulfiram (Antabuse) causes - ANS aversion reaction to ETOH (flushing, headaches, n/v,
palpitation, SOB, vertigo, hypotension)
disulfiram (Antabuse) Do not - ANS administer until the person has been alcohol free at least
12 hours
disulfiram (Antabuse) MOA - ANS Blocks enzyme (aldehyde dehydrogenase) in the liver
ETOH withdrawal- Benzos - ANS To keep patient calm and lightly sedated
Benzos MOA - ANS Enhance the effects of GABA
Meds used in mild alcohol withdrawal - ANS Tegretol, Valproic or Gabapentin
ETHO meds for nutritional deficiencies - ANS Thiamine, folic acid, and multivitamin - 'Banana
bag'
Wernicke's encephalopathy treatment - ANS Parenteral Thiamine and Folate
Wernicke's encephalopathy cause - ANS B1 deficiency
Cocaine mechanism - ANS reuptake of dopamine, epinephrine, and NE = Stimulant effect
Cocaine effects on the body - ANS has vasoconstrictive effects = can cause MI, stroke
Cocaine treatment options - ANS NO FDA approved med; Off-label = naltrexone, modafinil,
Topamax
2
@2026 EDITION ALLRIGHTS RESERVED
